Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 20.38.
Forward PE Ratio (20.38) = Close Price ($520.27) / Consensus Forward EPS ($25.52)
FORWARD PE RATIO
20.38
SECTOR MEDIAN · HEALTHCARE
20.29
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
+0.47%
vs the sector median at left
Chemed Corporation
Market Cap
$6.80B
Forward PE Ratio
20.38
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Chemed Corporation (CHE) | $6.80B | 20.38 |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.06B | N/A |
| Oscar Health, Inc. (OSCR)vs › | $7.79B | 18.12 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.35B | 20.81 |
| Doximity, Inc. (DOCS)vs › | $4.79B | 16.55 |
| Insulet Corp. (PODD)vs › | $9.93B | 22.05 |
| The Ensign Group, Inc. (ENSG)vs › | $10.11B | 22.26 |
| Henry Schein, Inc. (HSIC)vs › | $10.28B | 16.79 |
| Molina Healthcare, Inc. (MOH)vs › | $10.37B | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $3.17B | 61.33 |
Trailing P/E
26.1
reported TTM EPS
Forward P/E
20.4
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $25.52 implies +28.1% EPS growth vs the reported trailing $19.92.
At today's $520.27 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $25.52 | $24.89 – $26.16 | 2 | 20.4x |
| 2027-12-31 | $27.52 | $27.25 – $27.80 | 2 | 18.9x |
| 2028-12-31 | $29.33 | $29.23 – $29.38 | 1 | 17.7x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
